Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 623

1.

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

Dickler MN, Barry WT, Cirrincione CT, Ellis MJ, Moynahan ME, Innocenti F, Hurria A, Rugo HS, Lake DE, Hahn O, Schneider BP, Tripathy D, Carey LA, Winer EP, Hudis CA.

J Clin Oncol. 2016 May 2. pii: JCO661595. [Epub ahead of print]

PMID:
27138575
2.

Moral Injury, Spiritual Care and the Role of Chaplains: An Exploratory Scoping Review of Literature and Resources.

Carey LB, Hodgson TJ, Krikheli L, Soh RY, Armour AR, Singh TK, Impiombato CG.

J Relig Health. 2016 Apr 19. [Epub ahead of print]

PMID:
27094705
3.

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA.

JAMA Oncol. 2016 Apr 14. doi: 10.1001/jamaoncol.2016.0237. [Epub ahead of print]

PMID:
27078022
4.

Nonmicrobial Nitrophenol Degradation via Peroxygenase Activity of Dehaloperoxidase-Hemoglobin from Amphitrite ornata.

McCombs NL, D'Antonio J, Barrios DA, Carey LM, Ghiladi RA.

Biochemistry. 2016 May 3;55(17):2465-2478. Epub 2016 Apr 22.

PMID:
27070125
5.

Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.

Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB.

J Clin Oncol. 2016 Apr 11. pii: JCO658716. [Epub ahead of print]

PMID:
27069085
6.

TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.

Nagpal A, Kremer KL, Hamilton-Bruce MA, Kaidonis X, Milton AG, Levi C, Shi S, Carey L, Hillier S, Rose M, Zacest A, Takhar P, Koblar SA.

Int J Stroke. 2016 Mar 30. pii: 1747493016641111. [Epub ahead of print]

PMID:
27030504
7.

Another Breast Cancer Entity Confirmed: Genomics of Invasive Lobular Breast Cancer.

Gatza ML, Carey LA.

J Clin Oncol. 2016 Mar 28. pii: JCO663872. [Epub ahead of print] No abstract available.

PMID:
27022119
8.

Molecular genetic studies of complete hydatidiform moles.

Carey L, Nash BM, Wright DC.

Transl Pediatr. 2015 Apr;4(2):181-8. doi: 10.3978/j.issn.2224-4336.2015.04.02. Review.

9.

A synthetic gene circuit for measuring autoregulatory feedback control.

Schikora-Tamarit MÀ, Toscano-Ochoa C, Domingo Espinós J, Espinar L, Carey LB.

Integr Biol (Camb). 2016 Apr 18;8(4):546-55. doi: 10.1039/c5ib00230c. Epub 2016 Jan 5.

PMID:
26728081
10.

The Right Supramarginal Gyrus Is Important for Proprioception in Healthy and Stroke-Affected Participants: A Functional MRI Study.

Ben-Shabat E, Matyas TA, Pell GS, Brodtmann A, Carey LM.

Front Neurol. 2015 Dec 3;6:248. doi: 10.3389/fneur.2015.00248. eCollection 2015.

11.

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.

McKee MJ, Keith K, Deal AM, Garrett AL, Wheless AA, Green RL, Benbow JM, Dees EC, Carey LA, Ewend MG, Anders CK, Zagar TM.

Oncologist. 2016 Jan;21(1):16-20. doi: 10.1634/theoncologist.2015-0328. Epub 2015 Dec 9.

PMID:
26659221
12.
13.

Moral Injury: Unseen Wounds in an Age of Barbarism : By Tom Frame. 278 pp. Sydney: NewSouth Publishing, University of New South Wales. $33.95, ISBN 9781742234656 (paperback).

Carey L, Hodgson T, Cohen J.

J Relig Health. 2016 Feb;55(1):355-61. doi: 10.1007/s10943-015-0163-x. No abstract available.

PMID:
26607945
14.

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.

Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Carey LA, Troester MA, Wheeler SB.

J Clin Oncol. 2016 Jan 10;34(2):130-8. doi: 10.1200/JCO.2015.63.2489. Epub 2015 Nov 23.

PMID:
26598755
15.

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM.

JAMA Oncol. 2016 Jan 1;2(1):29-36. doi: 10.1001/jamaoncol.2015.3709.

PMID:
26539793
16.

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN, Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley KA, Iglesia M, Cheang MC, Perou CM, Winer EP, Hudis CA.

J Clin Oncol. 2016 Feb 20;34(6):542-9. doi: 10.1200/JCO.2015.62.1268. Epub 2015 Nov 2.

PMID:
26527775
17.

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.

Pangon L, Ng I, Giry-Laterriere M, Currey N, Morgan A, Benthani F, Tran PN, Al-Sohaily S, Segelov E, Parker BL, Cowley MJ, Wright DC, St Heaps L, Carey L, Rooman I, Kohonen-Corish MR.

Oncogene. 2015 Oct 12. doi: 10.1038/onc.2015.347. [Epub ahead of print]

PMID:
26455321
18.

What are the current guidelines and rationale for vancomycin monitoring?

Carey L.

JAAPA. 2015 Oct;28(10):19-20. doi: 10.1097/01.JAA.0000471490.62961.c2.

PMID:
26406173
19.

CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials.

Carey LA.

Clin Cancer Res. 2015 Sep 15;21(18):4027-9. doi: 10.1158/1078-0432.CCR-14-3124.

PMID:
26374072
20.

Rural Health and Spiritual Care Development: A Review of Programs across Rural Victoria, Australia.

Carey LB, Hennequin C, Krikheli L, O'Brien A, Sanchez E, Marsden CR.

J Relig Health. 2016 Jun;55(3):928-40. doi: 10.1007/s10943-015-0119-1.

PMID:
26350290
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk